Symfi Interactions
There are 854 drugs known to interact with Symfi (efavirenz/lamivudine/tenofovir disoproxil), along with 12 disease interactions, and 4 alcohol/food interactions. Of the total drug interactions, 386 are major, 453 are moderate, and 15 are minor.
- View all 854 medications that may interact with Symfi
- View Symfi alcohol/food interactions (4)
- View Symfi disease interactions (12)
Most frequently checked interactions
View interaction reports for Symfi (efavirenz / lamivudine / tenofovir disoproxil) and the medicines listed below.
- Actemra (tocilizumab)
- Adcetris (brentuximab)
- Adriamycin PFS (doxorubicin)
- Adriamycin RDF (doxorubicin)
- Advate (antihemophilic factor)
- Aptivus (tipranavir)
- Astagraf XL (tacrolimus)
- Atgam (lymphocyte immune globulin, anti-thy (equine))
- Avastin (bevacizumab)
- Banzel (rufinamide)
- Benadryl (diphenhydramine)
- Benlysta (belimumab)
- Besponsa (inotuzumab ozogamicin)
- Bexxar (iodine i 131 tositumomab)
- bezlotoxumab
- bleomycin
- Blincyto (blinatumomab)
- Celebrex (celecoxib)
- CellCept (mycophenolate mofetil)
- Cerdelga (eliglustat)
- Choletec (mebrofenin)
- Complera (emtricitabine / rilpivirine / tenofovir disoproxil)
- Corlanor (ivabradine)
- Cosentyx (secukinumab)
- Crixivan (indinavir)
- Cytovene (ganciclovir)
- Cytoxan Lyophilized (cyclophosphamide)
- Darzalex (daratumumab)
- Depakote Sprinkles (divalproex sodium)
- Dexedrine (dextroamphetamine)
Symfi alcohol/food interactions
There are 4 alcohol/food interactions with Symfi (efavirenz / lamivudine / tenofovir disoproxil).
Symfi disease interactions
There are 12 disease interactions with Symfi (efavirenz / lamivudine / tenofovir disoproxil) which include:
- hepatitis B
- hepatotoxicity
- pancreatitis
- cholesterol
- liver disease
- mental symptoms
- QT prolongation
- seizures
- renal dysfunction
- bone toxicity
- liver disease
- renal dysfunction
More about Symfi (efavirenz / lamivudine / tenofovir disoproxil)
- Symfi consumer information
- Compare alternatives
- Pricing & coupons
- Imprints, shape & color data
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: antiviral combinations
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.